questionsmedicales.fr
Acides nucléiques, nucléotides et nucléosides
Nucléotides
Ribonucléotides
Nucléoside diphosphate ose
Adénosine diphosphate ose
Adénosine diphosphate ribose
O-acétyl-ADP-ribose
O-acétyl-ADP-ribose : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Analyse Chromatographique
Spectrométrie de Masse
Tests Biochimiques
Dosage Enzymatique
Échantillons Sanguins
Méthodes de Mesure
Biomarqueurs
Niveaux Biologiques
Dysfonctionnement Cellulaire
Troubles Métaboliques
Symptômes
5
Douleur
Troubles Inflammatoires
Troubles Neurologiques
Études Cliniques
Symptômes Digestifs
Déséquilibres Métaboliques
Système Immunitaire
Réponse Immunitaire
Prévention
5
Mode de Vie Sain
Prévention des Maladies
Exercice Physique
Métabolisme
Suppléments
Consultation Médicale
Traitements
5
Inhibiteurs Enzymatiques
Modulateurs Métaboliques
Médicaments
Voies Métaboliques
Thérapies Alternatives
Suppléments Nutritionnels
Alimentation Équilibrée
Régulation Métabolique
Interventions Chirurgicales
Complications Médicales
Complications
5
Complications Métaboliques
Inflammation
Maladies Chroniques
Diabète
Troubles Cardiovasculaires
Études Épidémiologiques
Santé Mentale
Troubles Associés
Infections
Système Immunitaire
Facteurs de risque
5
Facteurs de Risque
Mode de Vie
Vieillissement
Santé Cellulaire
Mode de Vie Sédentaire
Déséquilibres Métaboliques
Maladies Préexistantes
Diabète
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "O-acétyl-ADP-ribose : Questions médicales les plus fréquentes",
"headline": "O-acétyl-ADP-ribose : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les O-acétyl-ADP-ribose : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-08",
"dateModified": "2025-03-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "O-acétyl-ADP-ribose"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Adénosine diphosphate ribose",
"url": "https://questionsmedicales.fr/mesh/D000246",
"about": {
"@type": "MedicalCondition",
"name": "Adénosine diphosphate ribose",
"code": {
"@type": "MedicalCode",
"code": "D000246",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.695.827.708.070.125"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "O-acétyl-ADP-ribose",
"alternateName": "O-Acetyl-ADP-Ribose",
"code": {
"@type": "MedicalCode",
"code": "D038961",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Anthony K L Leung",
"url": "https://questionsmedicales.fr/author/Anthony%20K%20L%20Leung",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA."
}
},
{
"@type": "Person",
"name": "Morgan Dasovich",
"url": "https://questionsmedicales.fr/author/Morgan%20Dasovich",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA."
}
},
{
"@type": "Person",
"name": "Mohsen Badiee",
"url": "https://questionsmedicales.fr/author/Mohsen%20Badiee",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205."
}
},
{
"@type": "Person",
"name": "Yong Zhang",
"url": "https://questionsmedicales.fr/author/Yong%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, California 90089, United States."
}
},
{
"@type": "Person",
"name": "Sua Myong",
"url": "https://questionsmedicales.fr/author/Sua%20Myong",
"affiliation": {
"@type": "Organization",
"name": "Program in Cell, Molecular, Developmental Biology, and Biophysics, Johns Hopkins University, Baltimore, Maryland 21218, United States."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Depersonalization disorder as a systematic downregulation of interoceptive signals.",
"datePublished": "2022-12-21",
"url": "https://questionsmedicales.fr/article/36543824",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-22277-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Embodying the (Dis)embodiment: Narrating Depersonalization-Derealization Disorder.",
"datePublished": "2022-08-31",
"url": "https://questionsmedicales.fr/article/36045636",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10497323221123763"
}
},
{
"@type": "ScholarlyArticle",
"name": "How vestibular dysfunction transforms into symptoms of depersonalization and derealization?",
"datePublished": "2022-12-22",
"url": "https://questionsmedicales.fr/article/36586207",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jns.2022.120530"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinical characteristics of 217 Chinese cases with depersonalization/derealization disorder.",
"datePublished": "2024-09-04",
"url": "https://questionsmedicales.fr/article/39232691",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12888-024-06028-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Assessing responsiveness to direct verbal suggestions in depersonalization-derealization disorder.",
"datePublished": "2022-07-17",
"url": "https://questionsmedicales.fr/article/35870293",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.psychres.2022.114730"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides nucléiques, nucléotides et nucléosides",
"item": "https://questionsmedicales.fr/mesh/D009706"
},
{
"@type": "ListItem",
"position": 3,
"name": "Nucléotides",
"item": "https://questionsmedicales.fr/mesh/D009711"
},
{
"@type": "ListItem",
"position": 4,
"name": "Ribonucléotides",
"item": "https://questionsmedicales.fr/mesh/D012265"
},
{
"@type": "ListItem",
"position": 5,
"name": "Nucléoside diphosphate ose",
"item": "https://questionsmedicales.fr/mesh/D009702"
},
{
"@type": "ListItem",
"position": 6,
"name": "Adénosine diphosphate ose",
"item": "https://questionsmedicales.fr/mesh/D000247"
},
{
"@type": "ListItem",
"position": 7,
"name": "Adénosine diphosphate ribose",
"item": "https://questionsmedicales.fr/mesh/D000246"
},
{
"@type": "ListItem",
"position": 8,
"name": "O-acétyl-ADP-ribose",
"item": "https://questionsmedicales.fr/mesh/D038961"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : O-acétyl-ADP-ribose - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur O-acétyl-ADP-ribose",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur O-acétyl-ADP-ribose",
"description": "Comment détecter l'O-acétyl-ADP-ribose dans les cellules ?\nQuels tests sont utilisés pour évaluer l'O-acétyl-ADP-ribose ?\nL'O-acétyl-ADP-ribose est-il mesurable dans le sang ?\nY a-t-il des biomarqueurs associés à l'O-acétyl-ADP-ribose ?\nQuels sont les indicateurs de dysfonctionnement de l'O-acétyl-ADP-ribose ?",
"url": "https://questionsmedicales.fr/mesh/D038961?mesh_terms=Depersonalization#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur O-acétyl-ADP-ribose",
"description": "Quels symptômes sont liés à des niveaux anormaux d'O-acétyl-ADP-ribose ?\nL'O-acétyl-ADP-ribose provoque-t-il des douleurs ?\nY a-t-il des symptômes neurologiques liés à l'O-acétyl-ADP-ribose ?\nDes symptômes digestifs peuvent-ils être liés à l'O-acétyl-ADP-ribose ?\nL'O-acétyl-ADP-ribose affecte-t-il le système immunitaire ?",
"url": "https://questionsmedicales.fr/mesh/D038961?mesh_terms=Depersonalization#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur O-acétyl-ADP-ribose",
"description": "Comment prévenir les déséquilibres d'O-acétyl-ADP-ribose ?\nY a-t-il des recommandations diététiques pour l'O-acétyl-ADP-ribose ?\nL'exercice physique aide-t-il à réguler l'O-acétyl-ADP-ribose ?\nLe stress influence-t-il l'O-acétyl-ADP-ribose ?\nDes suppléments peuvent-ils prévenir les déséquilibres d'O-acétyl-ADP-ribose ?",
"url": "https://questionsmedicales.fr/mesh/D038961?mesh_terms=Depersonalization#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur O-acétyl-ADP-ribose",
"description": "Quels traitements ciblent l'O-acétyl-ADP-ribose ?\nL'O-acétyl-ADP-ribose peut-il être traité par des médicaments ?\nY a-t-il des thérapies alternatives pour l'O-acétyl-ADP-ribose ?\nComment l'alimentation influence-t-elle l'O-acétyl-ADP-ribose ?\nDes interventions chirurgicales sont-elles nécessaires pour l'O-acétyl-ADP-ribose ?",
"url": "https://questionsmedicales.fr/mesh/D038961?mesh_terms=Depersonalization#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur O-acétyl-ADP-ribose",
"description": "Quelles complications peuvent survenir avec l'O-acétyl-ADP-ribose ?\nL'O-acétyl-ADP-ribose est-il lié à des maladies chroniques ?\nDes troubles cardiovasculaires peuvent-ils être liés à l'O-acétyl-ADP-ribose ?\nL'O-acétyl-ADP-ribose peut-il affecter la santé mentale ?\nY a-t-il des risques d'infection liés à l'O-acétyl-ADP-ribose ?",
"url": "https://questionsmedicales.fr/mesh/D038961?mesh_terms=Depersonalization#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur O-acétyl-ADP-ribose",
"description": "Quels facteurs de risque influencent l'O-acétyl-ADP-ribose ?\nL'âge est-il un facteur de risque pour l'O-acétyl-ADP-ribose ?\nLe tabagisme influence-t-il l'O-acétyl-ADP-ribose ?\nLe manque d'exercice est-il un facteur de risque ?\nDes maladies préexistantes augmentent-elles le risque d'O-acétyl-ADP-ribose ?",
"url": "https://questionsmedicales.fr/mesh/D038961?mesh_terms=Depersonalization#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment détecter l'O-acétyl-ADP-ribose dans les cellules ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques comme la chromatographie et la spectrométrie de masse sont utilisées."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'O-acétyl-ADP-ribose ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests biochimiques et les dosages enzymatiques sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "L'O-acétyl-ADP-ribose est-il mesurable dans le sang ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être mesuré dans des échantillons sanguins par des méthodes spécifiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des biomarqueurs associés à l'O-acétyl-ADP-ribose ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des biomarqueurs spécifiques peuvent indiquer des niveaux d'O-acétyl-ADP-ribose."
}
},
{
"@type": "Question",
"name": "Quels sont les indicateurs de dysfonctionnement de l'O-acétyl-ADP-ribose ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux peuvent indiquer des troubles métaboliques ou cellulaires."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à des niveaux anormaux d'O-acétyl-ADP-ribose ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes variés peuvent inclure fatigue, troubles métaboliques et inflammation."
}
},
{
"@type": "Question",
"name": "L'O-acétyl-ADP-ribose provoque-t-il des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut être associé à des douleurs dues à des troubles métaboliques ou inflammatoires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques liés à l'O-acétyl-ADP-ribose ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien potentiel avec des troubles neurologiques, mais c'est encore à explorer."
}
},
{
"@type": "Question",
"name": "Des symptômes digestifs peuvent-ils être liés à l'O-acétyl-ADP-ribose ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déséquilibres métaboliques peuvent entraîner des symptômes digestifs."
}
},
{
"@type": "Question",
"name": "L'O-acétyl-ADP-ribose affecte-t-il le système immunitaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut influencer la réponse immunitaire, entraînant des symptômes d'inflammation."
}
},
{
"@type": "Question",
"name": "Comment prévenir les déséquilibres d'O-acétyl-ADP-ribose ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain et équilibré peut aider à prévenir ces déséquilibres."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations diététiques pour l'O-acétyl-ADP-ribose ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en antioxydants et nutriments peut soutenir la santé cellulaire."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il à réguler l'O-acétyl-ADP-ribose ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer le métabolisme et réguler les niveaux d'O-acétyl-ADP-ribose."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il l'O-acétyl-ADP-ribose ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut perturber les niveaux d'O-acétyl-ADP-ribose et affecter la santé."
}
},
{
"@type": "Question",
"name": "Des suppléments peuvent-ils prévenir les déséquilibres d'O-acétyl-ADP-ribose ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains suppléments peuvent aider, mais il est essentiel de consulter un professionnel de santé."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent l'O-acétyl-ADP-ribose ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs enzymatiques et des modulateurs métaboliques sont explorés comme traitements."
}
},
{
"@type": "Question",
"name": "L'O-acétyl-ADP-ribose peut-il être traité par des médicaments ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches sont en cours pour développer des médicaments ciblant ses voies métaboliques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des thérapies alternatives pour l'O-acétyl-ADP-ribose ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines thérapies alternatives, comme les suppléments, sont étudiées mais nécessitent plus de preuves."
}
},
{
"@type": "Question",
"name": "Comment l'alimentation influence-t-elle l'O-acétyl-ADP-ribose ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut aider à réguler les niveaux d'O-acétyl-ADP-ribose."
}
},
{
"@type": "Question",
"name": "Des interventions chirurgicales sont-elles nécessaires pour l'O-acétyl-ADP-ribose ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "En général, les interventions chirurgicales ne sont pas nécessaires, sauf en cas de complications graves."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'O-acétyl-ADP-ribose ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications métaboliques et inflammatoires peuvent survenir en cas de déséquilibre."
}
},
{
"@type": "Question",
"name": "L'O-acétyl-ADP-ribose est-il lié à des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux anormaux peuvent être associés à des maladies chroniques comme le diabète."
}
},
{
"@type": "Question",
"name": "Des troubles cardiovasculaires peuvent-ils être liés à l'O-acétyl-ADP-ribose ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien potentiel entre les déséquilibres et les troubles cardiovasculaires."
}
},
{
"@type": "Question",
"name": "L'O-acétyl-ADP-ribose peut-il affecter la santé mentale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches indiquent qu'il pourrait influencer la santé mentale et les troubles associés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques d'infection liés à l'O-acétyl-ADP-ribose ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des déséquilibres peuvent affaiblir le système immunitaire, augmentant le risque d'infections."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque influencent l'O-acétyl-ADP-ribose ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme l'alimentation, le stress et le mode de vie peuvent influencer ses niveaux."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour l'O-acétyl-ADP-ribose ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut affecter les niveaux d'O-acétyl-ADP-ribose et la santé cellulaire."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il l'O-acétyl-ADP-ribose ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut perturber le métabolisme et affecter les niveaux d'O-acétyl-ADP-ribose."
}
},
{
"@type": "Question",
"name": "Le manque d'exercice est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire peut contribuer à des déséquilibres d'O-acétyl-ADP-ribose."
}
},
{
"@type": "Question",
"name": "Des maladies préexistantes augmentent-elles le risque d'O-acétyl-ADP-ribose ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies, comme le diabète, peuvent augmenter le risque de déséquilibres."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 03/03/2025
Contenu vérifié selon les dernières recommandations médicales
10 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.
McKusick-Nathans Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
5 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.
Department of Chemistry, Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore, MD 21218, USA.
Publications dans "O-acétyl-ADP-ribose" :
5 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205.
Publications dans "O-acétyl-ADP-ribose" :
4 publications dans cette catégorie
Affiliations :
Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, California 90089, United States.
Department of Chemistry, Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, California 90089, United States.
Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California 90089, United States.
Research Center for Liver Diseases, University of Southern California, Los Angeles, California 90089, United States.
Publications dans "O-acétyl-ADP-ribose" :
4 publications dans cette catégorie
Affiliations :
Program in Cell, Molecular, Developmental Biology, and Biophysics, Johns Hopkins University, Baltimore, Maryland 21218, United States.
Department of Biophysics, Johns Hopkins University, Baltimore, Maryland 21218, United States.
Physics Frontier Center (Center for the Physics of Living Cells), University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, United States.
Publications dans "O-acétyl-ADP-ribose" :
3 publications dans cette catégorie
Affiliations :
Department of Biomedical Sciences, Chung Shan Medical University, Taichung, Taiwan.
Publications dans "O-acétyl-ADP-ribose" :
3 publications dans cette catégorie
Affiliations :
Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan.
Publications dans "O-acétyl-ADP-ribose" :
3 publications dans cette catégorie
Affiliations :
Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.
Publications dans "O-acétyl-ADP-ribose" :
3 publications dans cette catégorie
Affiliations :
Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.
Publications dans "O-acétyl-ADP-ribose" :
3 publications dans cette catégorie
Affiliations :
Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.
Publications dans "O-acétyl-ADP-ribose" :
3 publications dans cette catégorie
Affiliations :
Department of Food Science and Biotechnology, Da-Yeh University, Changhua, Taiwan.
Publications dans "O-acétyl-ADP-ribose" :
3 publications dans cette catégorie
Affiliations :
Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan.
Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.
Department of Food Science and Biotechnology, Da-Yeh University, Changhua, Taiwan.
Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan.
Guang EM Laboratory, New Taipei, Taiwan.
Publications dans "O-acétyl-ADP-ribose" :
3 publications dans cette catégorie
Affiliations :
Laboratory of Signaling and Gene Regulation, Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Section of Laboratory Research, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address: Cristel.Camacho@utsouthwestern.edu.
Publications dans "O-acétyl-ADP-ribose" :
3 publications dans cette catégorie
Affiliations :
Department of Neurology, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.
Publications dans "O-acétyl-ADP-ribose" :
3 publications dans cette catégorie
Affiliations :
Department of Neurology, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.
Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.
Department of Neuroscience, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.
Publications dans "O-acétyl-ADP-ribose" :
3 publications dans cette catégorie
Affiliations :
Department of Neurology, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.
Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.
Department of Neuroscience, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.
Publications dans "O-acétyl-ADP-ribose" :
3 publications dans cette catégorie
Publications dans "O-acétyl-ADP-ribose" :
2 publications dans cette catégorie
Affiliations :
Institute of Molecular Biology, Academia Sinica, Taipei 115, Taiwan.
Publications dans "O-acétyl-ADP-ribose" :
2 publications dans cette catégorie
Affiliations :
Institute of Molecular Biology, Academia Sinica, Taipei 115, Taiwan.
Publications dans "O-acétyl-ADP-ribose" :
2 publications dans cette catégorie
Affiliations :
Molecular Toxicology Group, University of Konstanz, Konstanz, Germany.
Publications dans "O-acétyl-ADP-ribose" :
Depersonalisation disorder (DPD) is a psychopathological condition characterised by a feeling of detachment from one's own body and surrounding, and it is understood as emerging from the downregulatio...
Depersonalization-Derealization Disorder is an under-researched condition that is often left out of the larger discourse surrounding mental health and mental illness. This autoethnography examines the...
Psychiatric Depersonalization/Derealization (DPDR) symptoms were demonstrated in patients with peripheral vestibular disorders. However, only semicircular canals (SCCs) dysfunction was evaluated, ther...
We tested patients with peripheral Bilateral Vestibular Hypofunction (pBVH), Machado Joseph Disease (MJD) with cerebellar and central bilateral vestibular hypofunction, and healthy controls. Participa...
pBVH patients showed significant SCCs and sacculi dysfunction, spatial disorientation, elevated panic anxiety, and DPDR symptoms. MJD patients showed significant SCCs hypofunction but preserved saccul...
DPDR develops in association with sacculi dysfunction, either with or without SSCs dysfunction. Spatial disorientation and anxiety seem to mediate the transformation of vestibular dysfunction into DPD...
Depersonalization/derealization disorder (DPD) is a prevalent yet inadequately understood clinical condition characterized by a recurrent or persistent sense of unreality. This study aims to provide i...
The dissociative disorders and germane conditions are reliably characterized by elevated responsiveness to direct verbal suggestions. However, it remains unclear whether atypical responsiveness to sug...
Depersonalization-Derealization Disorder (DPD), a prevalent psychiatric disorder, fundamentally disrupts self-consciousness and could significantly impact the quality of life of those affected. While ...
In our study, we recruited 84 right-handed DPD patients and 67 healthy controls (HCs), assessing them using the Cambridge Depersonalization Scale and a subliminal self-face recognition task. We also c...
We identified distinct brain networks corresponding to the Frontoparietal Network (FPN), the Sensorimotor Network (SMN), and the Default Mode Network (DMN) in DPD using group Independent Component Ana...
Our study suggests the brain dynamics of DPD could be a potential biomarker for diagnosis and symptom analysis, which potentially leads to more personalized and effective treatment strategies for DPD ...
The trial was registered at the Chinese Clinical Trial Registry on 03/01/2021 (Registration number: ChiCTR2100041741, https://www.chictr.org.cn/showproj.html?proj=66731 ) before the trial....
Depersonalization-derealization disorder (DDD) is a dissociative disorder encompassing pronounced disconnections from the self and from external reality. As DDD is inherently tied to a detachment from...
We developed two online dance tasks to reduce detachment either by training body awareness (BA task) or enhancing the salience of bodily signals through dance exercise (DE task). Individuals with DDD ...
At baseline, individuals with DDD exhibited elevated depersonalization-derealization symptoms alongside lower levels of interoceptive awareness and mindfulness compared to controls. Both tasks reduced...
Individual and structured dance/movement practice, performed at home without an instructor present, offers an effective tool to reduce symptoms in DDD and can be tailored to address specific cognitive...
Previous research shows that virtual reality (VR) users may experience symptoms of depersonalization/derealization (DPDR) immediately after use. However, the impact of long-term VR use on these sympto...
The relationship binding body weight to psychological well-being is unclear. The present study aims at identifying the contribution, and specificity, of some dimensions (i.e., eating-related symptoms,...
By introducing the scores obtained by standardized self-report tools into a generalized linear model, a factorial reduction design was used to detect the best fitting discriminant functions and the pr...
We found two discriminant functions correctly classifying 87.1% of normal-weight, 57.2% of overweight, and 68.2% of obese adolescents. Furthermore, two independent factors, explaining 69.68% of the to...
The first factor, "Body Image Concerns", included the drive for thinness, body dissatisfaction, and interpersonal distrust. The second factor, "Selective Depersonalization", included a trend toward de...
We present novel research on the cortical dynamics of atypical perceptual and emotional processing in people with symptoms of depersonalization-derealization disorder (DP-DR). We used electroencephalo...